APO Research
Talk to an analyst

APO RESEARCH · REPORT

α-blocker

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global α-blocker Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025192 pages

Choose your research edition.

Industry Researchα-blocker Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal α-blocker Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal α-blocker Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal α-blocker Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal α-blocker Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global α-blocker market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for α-blocker is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for α-blocker is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for α-blocker is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for α-blocker is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of α-blocker include Teva Pharmaceutical, Sanofi, Jhonson and Johnson, Novartis, Merck, Eli Lilly, Pfizer, GSK and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global α-blocker market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of α-blocker and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents α-blocker sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the α-blocker market size, projected growth trends, production technologies, key applications, and end-use industries.

α-blocker Segment by Company

Teva Pharmaceutical

Sanofi

Jhonson and Johnson

Novartis

Merck

Eli Lilly

Pfizer

GSK

Bayer

Bristol-Myers Squibb

Astra Zeneca

α-blocker Segment by Type

Non-selective Antagonists

Selective Antagonists

α-blocker Segment by Application

Raynaud's Disease

Hypertension

Erectile Dysfunction

α-blocker Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global α-blocker market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of α-blocker and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of α-blocker.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the α-blocker market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of α-blocker manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of α-blocker in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of α-blocker in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. α-blocker Industry Trends Table 2. α-blocker Industry Drivers Table 3. α-blocker Industry Opportunities and Challenges Table 4. α-blocker Industry Restraints Table 5. Global α-blocker Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global α-blocker Revenue Market Share by Manufacturers (2021-2026) Table 7. Global α-blocker Sales by Manufacturers (k tons) & (2021-2026) Table 8. Global α-blocker Sales Market Share by Manufacturers Table 9. Global α-blocker Average Sales Price (US$/ton) of Manufacturers (2021-2026) Table 10. Global α-blocker Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global α-blocker Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global α-blocker Manufacturers, Product Type & Application Table 13. Global α-blocker Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global α-blocker by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Non-selective Antagonists Table 17. Major Manufacturers of Selective Antagonists Table 18. Global α-blocker Sales by Type 2021 VS 2025 VS 2032 (k tons) Table 19. Global α-blocker Sales by Type (2021-2026) & (k tons) Table 20. Global α-blocker Sales by Type (2027-2032) & (k tons) Table 21. Global α-blocker Sales Market Share by Type (2021-2026) Table 22. Global α-blocker Sales Market Share by Type (2027-2032) Table 23. Global α-blocker Revenue by Type 2021 VS 2025 VS 2032 (k tons) Table 24. Global α-blocker Revenue by Type (2021-2026) & (k tons) Table 25. Global α-blocker Revenue by Type (2027-2032) & (k tons) Table 26. Global α-blocker Revenue Market Share by Type (2021-2026) Table 27. Global α-blocker Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Raynaud's Disease Table 29. Major Manufacturers of Hypertension Table 30. Major Manufacturers of Erectile Dysfunction Table 31. Global α-blocker Sales by Application 2021 VS 2025 VS 2032 (k tons) Table 32. Global α-blocker Sales by Application (2021-2026) & (k tons) Table 33. Global α-blocker Sales by Application (2027-2032) & (k tons) Table 34. Global α-blocker Sales Market Share by Application (2021-2026) Table 35. Global α-blocker Sales Market Share by Application (2027-2032) Table 36. Global α-blocker Revenue by Application 2021 VS 2025 VS 2032 (k tons) Table 37. Global α-blocker Revenue by Application (2021-2026) & (k tons) Table 38. Global α-blocker Revenue by Application (2027-2032) & (k tons) Table 39. Global α-blocker Revenue Market Share by Application (2021-2026) Table 40. Global α-blocker Revenue Market Share by Application (2027-2032) Table 41. Global α-blocker Sales by Region: 2021 VS 2025 VS 2032 (k tons) Table 42. Global α-blocker Sales by Region (2021-2026) & (k tons) Table 43. Global α-blocker Sales Market Share by Region (2021-2026) Table 44. Global α-blocker Sales Forecasted by Region (2027-2032) & (k tons) Table 45. Global α-blocker Sales Forecasted Market Share by Region (2027-2032) Table 46. North America α-blocker Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 47. North America α-blocker Sales by Country (2021-2026) & (k tons) Table 48. North America α-blocker Sales by Country (2027-2032) & (k tons) Table 49. Europe α-blocker Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 50. Europe α-blocker Sales by Country (2021-2026) & (k tons) Table 51. Europe α-blocker Sales by Country (2027-2032) & (k tons) Table 52. Asia Pacific α-blocker Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 53. Asia Pacific α-blocker Sales by Country (2021-2026) & (k tons) Table 54. Asia Pacific α-blocker Sales by Country (2027-2032) & (k tons) Table 55. South America, Middle East and Africa α-blocker Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 56. South America, Middle East and Africa α-blocker Sales by Country (2021-2026) & (k tons) Table 57. South America, Middle East and Africa α-blocker Sales by Country (2027-2032) & (k tons) Table 58. Global α-blocker Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global α-blocker Revenue by Region (2021-2026) & (US$ Million) Table 60. Global α-blocker Revenue by Region (2027-2032) & (US$ Million) Table 61. Global α-blocker Revenue Market Share by Region (2021-2026) Table 62. Global α-blocker Revenue Market Share by Region (2027-2032) Table 63. Teva Pharmaceutical Company Information Table 64. Teva Pharmaceutical Business Overview Table 65. Teva Pharmaceutical α-blocker Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Teva Pharmaceutical α-blocker Product Portfolio Table 67. Teva Pharmaceutical Recent Development Table 68. Sanofi Company Information Table 69. Sanofi Business Overview Table 70. Sanofi α-blocker Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sanofi α-blocker Product Portfolio Table 72. Sanofi Recent Development Table 73. Jhonson and Johnson Company Information Table 74. Jhonson and Johnson Business Overview Table 75. Jhonson and Johnson α-blocker Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Jhonson and Johnson α-blocker Product Portfolio Table 77. Jhonson and Johnson Recent Development Table 78. Novartis Company Information Table 79. Novartis Business Overview Table 80. Novartis α-blocker Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Novartis α-blocker Product Portfolio Table 82. Novartis Recent Development Table 83. Merck Company Information Table 84. Merck Business Overview Table 85. Merck α-blocker Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Merck α-blocker Product Portfolio Table 87. Merck Recent Development Table 88. Eli Lilly Company Information Table 89. Eli Lilly Business Overview Table 90. Eli Lilly α-blocker Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Eli Lilly α-blocker Product Portfolio Table 92. Eli Lilly Recent Development Table 93. Pfizer Company Information Table 94. Pfizer Business Overview Table 95. Pfizer α-blocker Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Pfizer α-blocker Product Portfolio Table 97. Pfizer Recent Development Table 98. GSK Company Information Table 99. GSK Business Overview Table 100. GSK α-blocker Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. GSK α-blocker Product Portfolio Table 102. GSK Recent Development Table 103. Bayer Company Information Table 104. Bayer Business Overview Table 105. Bayer α-blocker Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Bayer α-blocker Product Portfolio Table 107. Bayer Recent Development Table 108. Bristol-Myers Squibb Company Information Table 109. Bristol-Myers Squibb Business Overview Table 110. Bristol-Myers Squibb α-blocker Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Bristol-Myers Squibb α-blocker Product Portfolio Table 112. Bristol-Myers Squibb Recent Development Table 113. Astra Zeneca Company Information Table 114. Astra Zeneca Business Overview Table 115. Astra Zeneca α-blocker Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Astra Zeneca α-blocker Product Portfolio Table 117. Astra Zeneca Recent Development Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. α-blocker Distributors List Table 121. α-blocker Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. α-blocker Product Image Figure 2. Global α-blocker Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global α-blocker Market Size (2021-2032) & (US$ Million) Figure 4. Global α-blocker Sales (2021-2032) & (k tons) Figure 5. Global α-blocker Average Price (US$/ton) & (2021-2032) Figure 6. Global Top 5 and 10 α-blocker Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Non-selective Antagonists Image Figure 9. Selective Antagonists Image Figure 10. Global α-blocker Sales by Type (2021 VS 2025 VS 2032) & (k tons) Figure 11. Global α-blocker Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global α-blocker Sales Market Share by Type (2021-2032) Figure 13. Global α-blocker Revenue by Type (2021 VS 2025 VS 2032) & (k tons) Figure 14. Global α-blocker Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global α-blocker Revenue Market Share by Type (2021-2032) Figure 16. Raynaud's Disease Image Figure 17. Hypertension Image Figure 18. Erectile Dysfunction Image Figure 19. Global α-blocker Sales by Application (2021 VS 2025 VS 2032) & (k tons) Figure 20. Global α-blocker Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global α-blocker Sales Market Share by Application (2021-2032) Figure 22. Global α-blocker Revenue by Application (2021 VS 2025 VS 2032) & (k tons) Figure 23. Global α-blocker Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global α-blocker Revenue Market Share by Application (2021-2032) Figure 25. North America α-blocker Sales and Growth Rate (2021-2032) & (k tons) Figure 26. North America α-blocker Sales Market Share by Country (2021-2032) Figure 27. U.S. α-blocker Sales and Growth Rate (2021-2032) & (k tons) Figure 28. Canada α-blocker Sales and Growth Rate (2021-2032) & (k tons) Figure 29. Mexico α-blocker Sales and Growth Rate (2021-2032) & (k tons) Figure 30. Europe α-blocker Sales and Growth Rate (2021-2032) & (k tons) Figure 31. Europe α-blocker Sales Market Share by Country (2021-2032) Figure 32. Germany α-blocker Sales and Growth Rate (2021-2032) & (k tons) Figure 33. France α-blocker Sales and Growth Rate (2021-2032) & (k tons) Figure 34. U.K. α-blocker Sales and Growth Rate (2021-2032) & (k tons) Figure 35. Italy α-blocker Sales and Growth Rate (2021-2032) & (k tons) Figure 36. Netherlands α-blocker Sales and Growth Rate (2021-2032) & (k tons) Figure 37. Asia Pacific α-blocker Sales and Growth Rate (2021-2032) & (k tons) Figure 38. Asia Pacific α-blocker Sales Market Share by Country (2021-2032) Figure 39. China α-blocker Sales and Growth Rate (2021-2032) & (k tons) Figure 40. Japan α-blocker Sales and Growth Rate (2021-2032) & (k tons) Figure 41. South Korea α-blocker Sales and Growth Rate (2021-2032) & (k tons) Figure 42. Southeast Asia α-blocker Sales and Growth Rate (2021-2032) & (k tons) Figure 43. India α-blocker Sales and Growth Rate (2021-2032) & (k tons) Figure 44. Australia α-blocker Sales and Growth Rate (2021-2032) & (k tons) Figure 45. South America, Middle East and Africa α-blocker Sales and Growth Rate (2021-2032) & (k tons) Figure 46. South America, Middle East and Africa α-blocker Sales Market Share by Country (2021-2032) Figure 47. Brazil α-blocker Sales and Growth Rate (2021-2032) & (k tons) Figure 48. South Africa α-blocker Sales and Growth Rate (2021-2032) & (k tons) Figure 49. Saudi Arabia α-blocker Sales and Growth Rate (2021-2032) & (k tons) Figure 50. Turkey α-blocker Sales and Growth Rate (2021-2032) & (k tons) Figure 51. Argentina α-blocker Sales and Growth Rate (2021-2032) & (k tons) Figure 52. UAE α-blocker Sales and Growth Rate (2021-2032) & (k tons) Figure 53. Egypt α-blocker Sales and Growth Rate (2021-2032) & (k tons) Figure 54. Chile α-blocker Sales and Growth Rate (2021-2032) & (k tons) Figure 55. Global α-blocker Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global α-blocker Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America α-blocker Revenue (2021-2032) & (US$ Million) Figure 58. North America α-blocker Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe α-blocker Revenue (2021-2032) & (US$ Million) Figure 60. Europe α-blocker Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific α-blocker Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific α-blocker Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa α-blocker Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa α-blocker Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. α-blocker Value Chain Figure 66. Manufacturing Cost Structure Figure 67. α-blocker Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Non-selective Antagonists
  • Selective Antagonists
Applications
  • Raynaud's Disease
  • Hypertension
  • Erectile Dysfunction
Companies covered
  • Teva Pharmaceutical
  • Sanofi
  • Jhonson and Johnson
  • Novartis
  • Merck
  • Eli Lilly
  • Pfizer
  • GSK
  • Bayer
  • Bristol-Myers Squibb
  • Astra Zeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global α-blocker Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global α-blocker Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global α-blocker Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global α-blocker Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global α-blocker Market Dynamics
  1. 2.1 α-blocker Industry Trends
  2. 2.2 α-blocker Industry Drivers
  3. 2.3 α-blocker Industry Opportunities and Challenges
  4. 2.4 α-blocker Industry Restraints
3 α-blocker Market by Manufacturers
  1. 3.1 Global α-blocker Revenue by Manufacturers (2021-2026)
  2. 3.2 Global α-blocker Sales by Manufacturers (2021-2026)
  3. 3.3 Global α-blocker Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global α-blocker Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global α-blocker Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global α-blocker Manufacturers, Product Type & Application
  7. 3.7 Global α-blocker Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global α-blocker Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 α-blocker Players Market Share by Revenue in 2025
  11. 3.8.3 2025 α-blocker Tier 1, Tier 2, and Tier 3
4 α-blocker Market by Type
  1. 4.1 α-blocker Type Introduction
  2. 4.1.1 Non-selective Antagonists
  3. 4.1.2 Selective Antagonists
  4. 4.2 Global α-blocker Sales by Type
  5. 4.2.1 Global α-blocker Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global α-blocker Sales by Type (2021-2032)
  7. 4.2.3 Global α-blocker Sales Market Share by Type (2021-2032)
  8. 4.3 Global α-blocker Revenue by Type
  9. 4.3.1 Global α-blocker Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global α-blocker Revenue by Type (2021-2032)
  11. 4.3.3 Global α-blocker Revenue Market Share by Type (2021-2032)
5 α-blocker Market by Application
  1. 5.1 α-blocker Application Introduction
  2. 5.1.1 Raynaud's Disease
  3. 5.1.2 Hypertension
  4. 5.1.3 Erectile Dysfunction
  5. 5.2 Global α-blocker Sales by Application
  6. 5.2.1 Global α-blocker Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global α-blocker Sales by Application (2021-2032)
  8. 5.2.3 Global α-blocker Sales Market Share by Application (2021-2032)
  9. 5.3 Global α-blocker Revenue by Application
  10. 5.3.1 Global α-blocker Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global α-blocker Revenue by Application (2021-2032)
  12. 5.3.3 Global α-blocker Revenue Market Share by Application (2021-2032)
6 Global α-blocker Sales by Region
  1. 6.1 Global α-blocker Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global α-blocker Sales by Region (2021-2032)
  3. 6.2.1 Global α-blocker Sales by Region (2021-2026)
  4. 6.2.2 Global α-blocker Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America α-blocker Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America α-blocker Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe α-blocker Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe α-blocker Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific α-blocker Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific α-blocker Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa α-blocker Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa α-blocker Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global α-blocker Revenue by Region
  1. 7.1 Global α-blocker Revenue by Region
  2. 7.1.1 Global α-blocker Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global α-blocker Revenue by Region (2021-2026)
  4. 7.1.3 Global α-blocker Revenue by Region (2027-2032)
  5. 7.1.4 Global α-blocker Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America α-blocker Revenue (2021-2032)
  8. 7.2.2 North America α-blocker Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe α-blocker Revenue (2021-2032)
  11. 7.3.2 Europe α-blocker Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific α-blocker Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific α-blocker Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa α-blocker Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa α-blocker Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical
  2. 8.1.1 Teva Pharmaceutical Company Information
  3. 8.1.2 Teva Pharmaceutical Business Overview
  4. 8.1.3 Teva Pharmaceutical α-blocker Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical α-blocker Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi α-blocker Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi α-blocker Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Jhonson and Johnson
  14. 8.3.1 Jhonson and Johnson Company Information
  15. 8.3.2 Jhonson and Johnson Business Overview
  16. 8.3.3 Jhonson and Johnson α-blocker Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Jhonson and Johnson α-blocker Product Portfolio
  18. 8.3.5 Jhonson and Johnson Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis α-blocker Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novartis α-blocker Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck α-blocker Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merck α-blocker Product Portfolio
  30. 8.5.5 Merck Recent Developments
  31. 8.6 Eli Lilly
  32. 8.6.1 Eli Lilly Company Information
  33. 8.6.2 Eli Lilly Business Overview
  34. 8.6.3 Eli Lilly α-blocker Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Eli Lilly α-blocker Product Portfolio
  36. 8.6.5 Eli Lilly Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer α-blocker Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer α-blocker Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 GSK
  44. 8.8.1 GSK Company Information
  45. 8.8.2 GSK Business Overview
  46. 8.8.3 GSK α-blocker Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GSK α-blocker Product Portfolio
  48. 8.8.5 GSK Recent Developments
  49. 8.9 Bayer
  50. 8.9.1 Bayer Company Information
  51. 8.9.2 Bayer Business Overview
  52. 8.9.3 Bayer α-blocker Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Bayer α-blocker Product Portfolio
  54. 8.9.5 Bayer Recent Developments
  55. 8.10 Bristol-Myers Squibb
  56. 8.10.1 Bristol-Myers Squibb Company Information
  57. 8.10.2 Bristol-Myers Squibb Business Overview
  58. 8.10.3 Bristol-Myers Squibb α-blocker Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bristol-Myers Squibb α-blocker Product Portfolio
  60. 8.10.5 Bristol-Myers Squibb Recent Developments
  61. 8.11 Astra Zeneca
  62. 8.11.1 Astra Zeneca Company Information
  63. 8.11.2 Astra Zeneca Business Overview
  64. 8.11.3 Astra Zeneca α-blocker Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Astra Zeneca α-blocker Product Portfolio
  66. 8.11.5 Astra Zeneca Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 α-blocker Value Chain Analysis
  2. 9.1.1 α-blocker Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 α-blocker Production Mode & Process
  6. 9.2 α-blocker Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 α-blocker Distributors
  9. 9.2.3 α-blocker Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst